Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1942-1961
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Figure 2 Prediction of diabetic retinopathy components and targets of action of Buqing granule therapy.
A: Main ingredients of Buqing granule (BQKL); B: BQKL-active ingredients-targets of action diagram (The rhombus, square hexagon, and square represent the herbal medicine, active ingredient, and target site, respectively); C: Venn diagram of BQKL and diabetic retinopathy (DR) intersection targets; D: Protein-ptrotein interaction network map and screened core BQKL targets for DR treatment (The darker the color, the larger the icon, the higher the degree value). TSZ: Tusizi; GQZ: Gouqizi; DGP: Digupi; CQZ: Cheqianzi; GJH: Ganjuhua; SDH: Shudihuang; BFL: Baifuling; DR: Diabetic retinopathy; BQKL: Buqing granule.
- Citation: Yang YF, Yuan L, Li XY, Liu Q, Jiang WJ, Jiao TQ, Li JQ, Ye MY, Niu Y, Nan Y. Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation. World J Diabetes 2024; 15(9): 1942-1961
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1942.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1942